Search results
Results from the WOW.Com Content Network
Genentech is a pioneering research-driven biotechnology company [14] that has continued to conduct R&D internally as well as through collaborations. [20] [21] Genentech's research collaborations include: In 2008 Genentech entered into a collaboration with Roche and its subsidiary GlycArt to develop obinutuzumab. [22]
[9] [10] During Anderson's tenure at Roche, he facilitated the company's transition from a focus on oncology. He headed the development and launch of new drugs to compensate for the decrease in revenues from oncology drugs whose patents had expired. [11] On June 1, 2023, Anderson assumed the role of CEO of Bayer AG, succeeding Werner Baumann. [12]
Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life threatening ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
oncology: Opdivo 7570 5763 6 pembrolizumab: oncology: Keytruda 7171 3809 7 etanercept: rheumatoid arthritis: Enbrel 7126 7885 8 trastuzumab: breast cancer: Herceptin 6981 7013 9 bevacizumab: colon cancer: Avastin 6847 6686 10 rituximab: non-Hodgkin's lymphoma: Rituxan, MabThera 6750 7298 11 rivaroxaban: anticoagulant: Xarelto 6589 6234 12 ...
Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of IFF. [1] Genencor is a producer of Industrial enzymes and low-priced bulk protein. The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982.
The FDA granted the application of polatuzumab vedotin breakthrough therapy, priority review, and orphan drug designations. [9] The FDA granted the approval of Polivy to Genentech. [9] Polatuzumab vedotin was approved for medical use in the European Union in January 2020, as a second-line treatment. [7]
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. [30] [28] For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma. [31]